Rojas, Ruperta .

HRN: 27-08-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2025
CEFTRIAXONE 1G (VIAL)
05/10/2025
05/17/2025
IV
2 Gram
OD
VAP
Waiting Final Action 
05/10/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/10/2025
05/15/2025
PO
500 Mg
OD
VAP
Waiting Final Action 
05/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/16/2025
05/22/2025
IVT
2 25g
Q8
CAP HR
Waiting Final Action 
05/24/2025
MUPIROCIN 2%, 15G (TUBE)
05/24/2025
05/30/2025
TOPICAL
Apply Thin Coat
BID
Decubitus Ulcer
Checking Initial Appropriateness 
05/25/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/25/2025
05/31/2025
TOPICAL
Thin Coat
Bid
Decubitus Ulcer
Waiting Final Action 
05/31/2025
MUPIROCIN 2%, 15G (TUBE)
05/31/2025
06/06/2025
TOPICAL
N/A
OD
Cellulitis, Paraumbilical Area
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: